Amita Oza, MD
Internal Medicine · Dayton, OHNPI 1285634865
Payments from drug & device makers
Across 566 payments — averaging $345.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$182K
- Shionogi Inc$5K
- AstraZeneca$3K
- Lilly USA, LLC$813
- Johnson & Johnson$808
- Pfizer$702
- plus $3K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 214 | $182,354 |
| Shionogi Inc | 1 | $5,216 |
| AstraZeneca | 107 | $2,538 |
| Lilly USA, LLC | 38 | $813 |
| Johnson & Johnson | 40 | $808 |
| Pfizer | 47 | $702 |
| Novo Nordisk | 35 | $682 |
| Bayer | 17 | $389 |
| GSK | 9 | $355 |
| Teva Pharmaceuticals USA, Inc. | 6 | $331 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $145 |
| Astellas Pharma US Inc | 1 | $129 |
| Abbott | 6 | $108 |
| Boehringer Ingelheim | 7 | $107 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $92 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $72 |
| Mylan Specialty L.p. | 1 | $64 |
| Esperion Therapeutics, Inc. | 1 | $62 |
| Biohaven Pharmaceuticals, Inc. | 2 | $53 |
| Orexo US, Inc. | 4 | $49 |
| Merck | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Alkermes, Inc. | 1 | $29 |
| Novartis | 1 | $21 |
| Exact Sciences | 1 | $18 |
| Renalytix AI, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Amgen | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Circassia Inc. | 1 | $13 |
How this compares
$195,386 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Dayton
- Ugochukwu NwokoroDayton$975K
- Richard KimDayton$374K
- Isaac HumphreyDayton$224K
- Antoinette PragalosCincinnati$27.8M
- Steven FolkerthBeavercreek$9.1M
- Charles EgerCincinnati$8.7M
- Vadim KoshkinCleveland$6.1M
- Nizar DaboulMaumee$4.7M
- Douglas LoganCincinnati$4.7M
- Seref BornovaliLoveland$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.